• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

  • ID: 1323075
  • June 2015
  • 42 pages
  • GlobalData

FEATURED COMPANIES

  • Arthrex, Inc.
  • ArthroCare Corporation
  • OLYMPUS CORPORATION
  • WEIFA AS
  • MORE

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arthrex, Inc.
  • ArthroCare Corporation
  • OLYMPUS CORPORATION
  • WEIFA AS
  • MORE

List of Tables
List of Figures
Section 1 - About the Company
Navamedic ASA - Key Facts
Navamedic ASA - Key Employees
Navamedic ASA - Key Employee Biographies
Navamedic ASA - Major Products and Services
Navamedic ASA - History
Navamedic ASA - Company Statement
Navamedic ASA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Navamedic ASA - Business Description
Navamedic ASA - Corporate Strategy
Navamedic ASA - SWOT Analysis
SWOT Analysis - Overview
Navamedic ASA - Strengths
Strength - Increase in Sales Revenue
Strength - Core Segment: Pharma
Strength - Strategic Partnerships
Navamedic ASA - Weaknesses
Weakness - Decline in Cash Flows
Navamedic ASA - Opportunities
Opportunity - New Product Launches
Opportunity - Growth Prospects: Generics Market
Opportunity - Changing Demographics
Navamedic ASA - Threats
Threat - Intense Competition
Threat - Influx of Generics
Threat - Stringent Government Regulations
Navamedic ASA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Navamedic ASA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2015: Navamedic first quarter results 2015
Feb 27, 2015: Navamedic Announces fourth quarter report 2014
Oct 31, 2014: Navamedic Q3 2014 Results
Aug 22, 2014: Navamedic Announces second quarter 2014 financial results
Aug 22, 2014: Navamedic Q2 2014 results
Mar 04, 2014: Navamedic expands female care product group
Feb 26, 2014: Improved sales and operating result for Navamedic
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Navamedic ASA, Key Facts
Navamedic ASA, Key Employees
Navamedic ASA, Key Employee Biographies
Navamedic ASA, Major Products and Services
Navamedic ASA, History
Navamedic ASA, Subsidiaries
Navamedic ASA, Key Competitors
Navamedic ASA, Ratios based on current share price
Navamedic ASA, Annual Ratios
Navamedic ASA, Interim Ratios
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Navamedic ASA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Navamedic ASA, Performance Chart (2010 - 2014)
Navamedic ASA, Ratio Charts
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015

Note: Product cover images may vary from those shown

OLYMPUS CORPORATION
Arthrex, Inc.
ArthroCare Corporation
WEIFA AS
Nycomed International Management GmbH

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Grifols, S.A. Takeda Pharmaceutical Company Limited Alexion Pharmaceuticals Teva Pharmaceutical Industries Ltd. Endo International Plc. Essilor International S.A.